Healthcare Professionals

Proveca medicines for children

This section is intended for Healthcare Professionals only and contains promotional content.

Neurology

Sialanar® (400mcg/ml glycopyrronium bromide)

Sialanar® (400mcg/ml glycopyrronium bromide)

Sialanar® (400mcg/ml glycopyrronium bromide) is licensed for the symptomatic treatment of severe sialorrhoea (chronic pathological drooling) due to chronic neurological disorders of childhood onset in patients aged 3 years and older.

Prescribing Information More Information

Cardiology

Aqumeldi® (enalapril maleate) 0.25mg and 1mg orodispersible mini tablets

Aqumeldi® is indicated for the treatment of heart failure in children from birth to less than 18 years.

Prescribing Information More Information

Please see information below to report adverse events in the UK

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Proveca Limited.
Phone: 0333 200 1866 E-mail: medinfo@proveca.com

This is our UK website, intended for UK Healthcare Professionals (HCPs). Our global and country sites can be reached by the selection bar in the top right hand corner.